Phase 2 study of anti-human cytomegalovirus monoclonal antibodies for prophylaxis in hematopoietic cell transplantation

10.1128/AAC.02467-19

Saved in:

Bibliographic Details
Main Authors:	Maertens, J, Logan, AC, Jang, J, Long, G, Tang, JL, Hwang, WYK, Koh, LP, Chemaly, R, Gerbitz, A, Winkler, J, Yeh, SP, Hiemenz, J, Christoph, S, Lee, DG, Wang, PN, Holler, E, Mielke, S, Akard, L, Yeo, A, Ramachandra, S, Smith, K, Pertel, P, Segal, F
Other Authors:	MEDICINE
Format:	Article
Published:	American Society for Microbiology 2022
Subjects:	hematopoietic stem cell transplantation human cytomegalovirus prophylaxis Administration, Intravenous Adult Aged Antibodies, Viral Antiviral Agents Cytomegalovirus Infections Female Graft vs Host Disease Hematopoietic Stem Cell Transplantation Humans Male Middle Aged Placebos Treatment Outcome Viral Load Young Adult
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/228766
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items